Accessibility StatementSkip Navigation LOS ANGELES, Sept. 18, 2025 /PRNewswire/ --  The DJS Law Group announces that it is investigating claims on behalf of investors of aTyr Pharma, Inc. ("aTyr" or "the Company") (NASDAQ: ATYR) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors. On September 15, 2025, Reuters reported that, "aTyr Pharma said on Monday its ...